Document Detail


AIDS 2010--XVIII International AIDS Conference.
MedLine Citation:
PMID:  20799144     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The AIDS 2010-XVIII International AIDS Conference, held in Vienna, included topics covering new therapeutic developments in the field of HIV therapy. This conference report highlights selected presentations on novel HIV entry inhibitors, reverse transcriptase inhibitors, integrase inhibitors and clinical trial data for an NRTI-based, antiviral, hyperactivation-limiting therapeutic. Investigational drugs discussed include GSK-1349572 (Viiv Healthcare/Shionogi & Co Ltd) and VS-411 (ViroStatics).
Authors:
Belete A Desimmie
Related Documents :
12048944 - Regularities of the physical world and the absence of their internalization.
17459174 - Trajectories of internalizing problems across childhood: heterogeneity, external validi...
3969394 - The magnitude of the problem of congenital malformations.
12061364 - Psychological well-being of orphans in dar el salaam, tanzania.
19068554 - Factors contributing to possession of walking aids among persons with osteoarthritis of...
21227094 - Dense heterarchies and mass communication as the basis of organization in ant colonies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  IDrugs : the investigational drugs journal     Volume:  13     ISSN:  2040-3410     ISO Abbreviation:  IDrugs     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-27     Completed Date:  2010-11-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883655     Medline TA:  IDrugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  622-5     Citation Subset:  IM    
Affiliation:
Katholieke Universiteit Leuven, Lab Moleculaire Virologie & Gentherapie, Kapucijnenvoer 33, Leuven, Belgium. belete.desimmie@med.kuleuven.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-HIV Agents / adverse effects,  pharmacology*
Clinical Trials as Topic
Drug Design
Drugs, Investigational / pharmacology*
HIV Infections / drug therapy*,  virology
Humans
Chemical
Reg. No./Substance:
0/Anti-HIV Agents; 0/Drugs, Investigational

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  International Society for Eye Research - XIXth Biennial Meeting.
Next Document:  Overcoming RNAi transduction in leukocytes using targeted and stabilized nanoparticles.